NetraMark Holdings Inc. (the 'Company” or 'NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company transforming clinical trials with AI-powered ...
Researchers at McMaster University have identified, for the first time, a novel region of DNA and two associated genes ...
In the field of agriculture and food production, the increasing global population pressures necessitate not only enhanced ...
The rapid advancement of spatial and single-cell omics technologies has revolutionized molecular biosciences by enabling high-resolution profiling of gene ...
The Special Supplemental Nutrition Program for Women, Infants, and Children, popularly known as WIC, serves more than 6 ...
A fast-track method of breeding disease-resistant ash trees has been developed by researchers leading efforts to conserve the ...
Twelve months after releasing a roadmap to shift away from animal testing requirements, the FDA has declared mission ...
Over the past 13 years, 25 out of 30 USDA inspections reported no findings at the Ridglan Farms research facility.
A research team at the Helmholtz-Zentrum Hereon has demonstrated how a classic technique can be repurposed to measure the ...
Explore how evolving obesity research is shaping trial design, with a focus on precision, reproducibility, and clinical ...
Animal testing has shaped medicine for decades. Discover new alternatives, changing laws, and the future of humane science.
Researchers have identified a versatile enzyme capable of reshaping peptide-based drugs into more stable, longer-lasting forms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results